🔎 Trials Near Me

Akèy › Kansè renn › Washington › Seattle

Etid klinik pou Kansè renn nan Seattle, WA

8 etid pou Kansè renn ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Ap rekriteFaz 1
  • Swedish Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06234605

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Ap rekriteFaz 3
  • Research Site, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07011719

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Ap rekriteEtid obsèvasyon
  • Fred Hutchinson Cancer Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04981119

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Ap rekriteFaz 1/2
  • Fred Hutchinson Cancer Center, Seattle
  • University Of Washington Medical Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07227415

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Ap rekriteFaz 1
  • Xencor Investigative Site, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT05433142

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Seattle
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Ap rekriteFaz 1/2
  • Fred Hutch Cancer Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT06682793

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Ap rekriteEtid obsèvasyon
  • Swedish Hospital, Seattle
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2022 · NCT05363657

Etid Kansè renn nan lòt vil

Lòt etid nan Seattle

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.